Stay updated on FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial

Sign up to get notified when there's something new on the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page shows Revision: v3.5.4, replacing the previous v3.5.3, indicating an administrative update to the page. The change does not alter the study details or user-facing features.
    Difference
    0.1%
    Check dated 2026-05-14T22:34:21.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page's revision tag changed from v3.5.2 to v3.5.3, indicating a newer release version of the page.
    Difference
    0.1%
    Check dated 2026-04-30T18:06:15.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:54:52.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0. No visible changes to the Study Details page content or layout.
    Difference
    0.1%
    Check dated 2026-03-18T18:14:12.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3, indicating a recent page update. No substantive study details or user-facing content were changed.
    Difference
    0.1%
    Check dated 2026-03-11T17:49:20.000Z thumbnail image
  8. Check
    106 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the funding-status notice and Revision: v3.4.1. These are administrative updates to the site and do not alter study details or eligibility information.
    Difference
    0.4%
    Check dated 2026-02-11T02:51:58.000Z thumbnail image

Stay in the know with updates to FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page.